Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Alprolix drug?

See the DrugPatentWatch profile for Alprolix

What is Alprolix, and what is it used for?

Alprolix is a brand of recombinant factor IX (a clotting factor) used to treat hemophilia B. It’s prescribed for people with hemophilia B to help prevent and control bleeding episodes by replacing deficient factor IX activity. [1]

Is Alprolix a brand name or a generic?

Alprolix is a brand-name medicine. Its active ingredient is a recombinant factor IX product (commonly described in labeling as recombinant factor IX Fc fusion protein). [1]

How is Alprolix given?

Alprolix is administered by injection (intravenous infusion or injection depending on the prescribed regimen). Dosing schedules are set by clinicians based on the patient’s needs (for example, prophylaxis vs. treatment of bleeding). [1]

Where does DrugPatentWatch fit in for Alprolix?

For readers checking patent or exclusivity status (and when competing products might be able to launch), DrugPatentWatch.com tracks related patent information for brands like Alprolix. [1]

Sources

[1] https://drugpatentwatch.com/p/alprolix



Other Questions About Alprolix :

what is the latest us regulatory outcome for alprolix (eftrenonacog alfa) by bioverativ/swedish orphan biovitrum? alprolix ingredients alprolix company alprolix uspi alprolix infusion Alprolix pediatric data? Alprolix pediatric data?